M. De Bruin

First name
Middle name
Last name
De Bruin
van Staa, T. P., Patel, D., Gallagher, A. M., & De Bruin, M. L. (2012). Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. Diabetologia. http://doi.org/10.1007/s00125-011-2390-3
Peeters, P. J., Bazelier, M. T., Uitdehaag, B. M., Leufkens, H. G., De Bruin, M. L., & de Vries, F. (2014). The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink. J Thromb Haemost. http://doi.org/10.1111/jth.12523
Duijnhoven, R. G., Straus, S. M., Souverein, P. C., de Boer, A., Bosch, J. L., Hoes, A. W., & De Bruin, M. L. (2014). Long-term use of 5alpha-reductase inhibitors and the risk of male breast cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-014-0455-6
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., et al. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
Peeters, P. J., Bazelier, M. T., Leufkens, H. G., de Vries, F., & De Bruin, M. L. (2015). The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Diabetes Care. http://doi.org/10.2337/dc14-1175
Goossens, M. E., Zeegers, M. P., Bazelier, M. T., De Bruin, M. L., Buntinx, F., & de Vries, F. (2015). Risk of bladder cancer in patients with diabetes: a retrospective cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2014-007470
Goossens, M. E., Buntinx, F., Zeegers, M. P., Driessen, J. H., De Bruin, M. L., & de Vries, F. (2015). Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12740
Stolwijk, C., Essers, I., van Tubergen, A., Boonen, A., Bazelier, M. T., De Bruin, M. L., & de Vries, F. (2015). The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-205253
Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., et al. (2016). Use of incretin agents and risk of pancreatic cancer: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12605
Warnier, M. J., Rutten, F. H., Souverein, P. C., de Boer, A., Hoes, A. W., & De Bruin, M. L. (2015). Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3792